Inventurus Knowledge Solutions Ltd.’s initial public offering is scheduled to open on Dec. 12. The Rekha Jhunjhunwala-backed firm’s IPO consists entirely of an offer for sale of 1.8 crore shares.

The price band for the IPO has been set in the range between Rs 1,265 and Rs 1,329 per share.

Promoters selling their shares include Ashra Family Trust, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust and Nishtha Jhunjhunwala Discretionary Trust.

IKS Health IPO: Details

  • Issue opens: Dec.12.

  • Issue closes: Dec.16.

  • Issue price: Rs 1,265 to Rs 1,329 per share.

  • Offer for sale: Rs 2,497.92 crore.

  • Fresh issue: Nil.

  • Total issue size: Rs 2,497.92 crore.

  • Lot size: Minimum 11 shares.

Use Of Proceeds

Since the Inventurus Knowledge Solutions IPO is entirely an OFS issue, proceeds from the offer will go directly to the selling shareholders. Joseph Benardello, Gautam Char, Jeffrey Philip Freimark are other investors selling their stake.

Business

The Inventurus Knowledge Solutions uses technology to help healthcare providers in the US, Canada, and Australia, especially in the US. They work with both outpatient (non-hospital) and inpatient (hospital) care centres to help them improve patient care, reduce costs, and optimise their finances. They work with healthcare organisations, managing their backend and administrative work

The company’s objective is to help clients focus on “core” operations, while it handles their “chores” or administrative tasks.

Financial Performance

Future Growth Strategies

  • Maximise revenue from existing clients through a “land and expand” approach.

  • Focus on large healthcare organisations.

  • Partner with clients for product development and innovation.

  • Move from a “human-led tech-enabled” model to a “tech-led human-enabled” model.

IKS Health IPO: Key Risks

  • Challenges in the US healthcare industry, such as delivering quality care, managing costs, and market consolidation, could negatively impact company’s business and finances.

  • Company’s revenues are primarily dependent on revenue generated from healthcare organisations based in the United States, and as a result, they are subject to the risks of sector and geographic concentration.

  • A significant portion of the company’s revenue comes from a few key clients. In recent times, the top 10 clients contributed 34-68% of its revenue. Losing any of them could severely impact their business and finances.

  • The company has outstanding litigation, an adverse outcome of which could impact business, reputation and results of operations.

Inventurus Knowledge Solutions IPO GMP

Inventurus Knowledge Solutions IPO’s last GMP is Rs 422 as of 7:23 a.m. on Dec. 12, according to InvestorGain. This implies shares of the company will likely list at Rs 1,751 apiece, indicating 31.75% gain over the upper limit of the price band.

It is important to note that GMP or grey market price is not an official price quote for the stock and is based on speculation.

Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read red herring prospectus thoroughly before placing bids.

. Read more on IPOs by NDTV Profit.Price band for the IPO of IKS Health parent has been set in the range of Rs 1,265–1,329 per share.  Read MoreIPOs, Markets, Business, Notifications 

​NDTV Profit